Author:
Carter Sean W. D.,Fee Erin L.,Usuda Haruo,Oguz Gokce,Ramasamy Adaikalavan,Amin Zubair,Agnihotri Biswas,Wei Qin,Xiawen Liu,Takahashi Tsukasa,Takahashi Yuki,Ikeda Hideyuki,Kumagai Yusaku,Saito Yuya,Saito Masatoshi,Mattar Citra,Evans Mark I.,Illanes Sebastián E.,Jobe Alan H.,Choolani Mahesh,Kemp Matthew W.
Publisher
Springer Science and Business Media LLC
Reference88 articles.
1. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10 Supp 1(Suppl 1):S2.
2. McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12:CD004454.
3. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2007;4:1–144.
4. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:1–191.
5. Norman J, Shennan A, Jacobsson B, Stock SJ, Birth FWGfP. FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. Int J Gynaecol Obstet. 2021;155(1):26–30.